The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease
Neurodegenerative diseases are a major public health problem worldwide with a wide spectrum of symptoms and physiological effects. It has been long reported that the dysregulation of the cholinergic system and the adrenergic system are linked to the etiology of Alzheimer’s disease. Cholinergic neuro...
Main Author: | Rola A. Bekdash |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/3/1273 |
Similar Items
-
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
by: Yu-Jung Cheng, et al.
Published: (2021-02-01) -
The Interaction of Cholinergic Muscarinic and Beta-1 Adrenergic Receptors of the CA1 Region in Passive Avoidance Memory Formation in Rat
by: S Bemani-Lirgeshasi, et al.
Published: (2014-01-01) -
Adrenergic, serotonergic and cholinergic control of testicular blood flow in the rat.
Published: (1995) -
Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
by: Ziqing Shi, et al.
Published: (2020-11-01) -
Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
by: Gabriela Dumitrita Stanciu, et al.
Published: (2019-12-01)